Find a Clinical Trial
Filter
Collagen Urine Assay
Male
50-80
Recruiting now
Department of Urology
Treatment Combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in Patients With Muscle Invasive Bladder Cancer Ineligible to Cisplatin or Who Refuse Cisplatin (VOLGA)
Bladder cancer
All genders
18+
Recruiting now
Department of Medicine, Cancer Center
LYS228 Pharmacokinetics for Complicated UTI
Urinary tract infections
All genders
18-85
Recruiting now
Department of Urology
A clinical trial investigating BNT113 in combination with pembrolizumab versus pembrolizumab alone for patients with a form of head and neck cancer positive for human papilloma virus 16 and expressing the protein PD-L1
Head and neck cancer
All genders
18+
Recruiting now
Cancer Center
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Squamous cell carcinoma
All genders
18+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
EA3191
Head and neck cancer
All genders
18-79
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
Exploring the Role of the Mineralocorticoid Receptor in Human Vascular Disease
Vascular diseases
All genders
18+
Recruiting now
Department of Surgery, Division of Vascular Surgery
Feasibility of a new method for non-invasive monitoring of low-grade bladder cancer
Bladder cancer
All genders
18-90
Recruiting now
Department of Urology
VAPOR 2
Prostate cancer
All genders
50-89
Recruiting now
Department of Urology